Skip to main navigation

Corporate Menu & Investor Relations

Contact Patients

Mission Leadership Community

The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications

Overview TC-210 TC-110 Pipeline

Press Releases In the News Awards

Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs

Careers

Corporate Menu & Investor Relations

About Us Mission Leadership Community Technology The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications Programs Overview TC-210 TC-110 Pipeline News Press Releases In the News Awards Investors Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs Careers Careers Contact Patients

Presentations

Presentations

Corporate Presentation

TCR² Corporate Presentation - September 2021 6.3 MB

gavo-cel Phase 1/2 Clinical Update

gavo-cel Phase 1/2 Clinical Update 1.6 MB

April 2021 - AACR

Engineering Off-the-shelf T Cell Receptor Fusion Construct (TRuC) T Cells Targeting Mesothelin 3.9 MB

Discovery and Preclinical Characterization of Fratricide-resistant TRuC-T Cells Targeting CD70 723.4 KB

Preliminary Safety and Efficacy of gavocabtagene autoleucel (gavo-cel, TC-210), a T Cell Receptor Fusion Construct (TRuC®), in Patients with Treatment Refractory Mesothelin Overexpressing Solid Tumors 3.1 MB

Preliminary Safety and Efficacy of gavocabtagene autoleucel (gavo-cel, TC-210),…

Discovery and Preclinical Characterization of Fratricide-resistant TRuC-T Cells…

Engineering Off-the-shelf T Cell Receptor Fusion Construct (TRuC) T Cells Targe…

Interim Clinical Data from Gavo cel (TC 210) Patients

Interim Clinical Data from Gavo cel (TC 210) Patients 1.4 MB

TC-210 Phase 1 Interim Data

TC-210 Phase 1 Interim Data 5.3 MB

June 2020 - AACR Virtual Annual Meeting II

A Chimeric PD1-CD28 Switch Receptor Enhances the Activity of TRuC-T Cells 2.7 MB

Engineering Off-the-Shelf T Cell Receptor Fusion Construct (TRuC™) T Cells 11.3 MB

February 2020 - Keystone Symposia

Engineering Off-the-Shelf T Cell Receptor Fusion Construct (TRuC^TM) T Cells 5.1 MB

April 2019 - AACR

Preclinical Evaluation of TC-110: CD19-Specific T Cell Receptor (TCR) Fusion Construct (TRuC^TM) T Cells for the Treatment of Hematologic Malignancy 4.5 MB

Preclinical Evaluation of TC-210: A Mesothelin-Specific T Cell Receptor (TCR) Fusion Construct (TRuC^TM) T Cells for the Treatment of Solid Tumors 7.2 MB

Tools

Print Page
RSS Feeds
Email Alerts
Contact IR

100 Binney Street, Suite 710
Cambridge, MA 02142
617.949.5200

Corporate Menu & Investor Relations

About Us
Technology
Programs
News
Investors
Careers
Contact
Patients